NIH-funded research R01 grant

Personalized epinephrine dosing for children during in-hospital cardiac arrest

Official title: Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest (PEDICA)

Funded at Children's Hosp of Philadelphia · NIH-11115712 · Data updated 2026-11-12

This project gives epinephrine doses based on a child's blood pressure during in-hospital cardiac arrest to try to help doctors restart the heart in children.

More Cardiac Arrest research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionChildren's Hosp of Philadelphia
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$795,410
NIH project number5R01HL175433-02
Project IDNIH-11115712 on NIH RePORTER

Who could benefit from this research

Could help

Children 0–11 years old who experience in-hospital cardiac arrest and receive CPR with arterial blood pressure monitoring would be the intended participants.

Less likely to help

This would not apply to out-of-hospital cardiac arrests, adults, or situations where arterial blood pressure cannot be monitored during CPR.

What this research studies

If your child has a cardiac arrest in the hospital, doctors would use real-time blood pressure readings during CPR to guide how much epinephrine to give. The team will track each child's diastolic blood pressure response to doses and use that physiology to choose personalized dosing rather than a single standard dose for everyone. They will compare outcomes such as whether the heart restarts (return of spontaneous circulation) and survival to hospital discharge. The approach builds on earlier data showing varied blood pressure responses and aims to find dosing that improves outcomes for children.

Why it matters

Potential benefit: If successful, this approach could increase the chances of restarting the heart and surviving to hospital discharge by tailoring epinephrine to a child's physiology.

How similar studies have gone: Early laboratory work and a 2023 clinical study showed variable blood pressure responses to epinephrine and linked larger increases to better immediate outcomes, so this builds on promising but not yet definitive data.

Where this research is happening

  • Children's Hosp of Philadelphia
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Morgan, Ryan William — Children's Hosp of Philadelphia
  • Study coordinator: Morgan, Ryan William

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.